Nordwand Advisors’s AstraZeneca AZN Stock Holding History

Nordwand Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$29.4K	–	177
2025 Q1	$29.4K	Hold	200	–	–	0.01%	59
2024 Q4	$26.2K	Hold	200	–	–	0.01%	64
2024 Q3	$31.2K	Hold	200	–	–	0.01%	63
2024 Q2	$31.2K	Hold	200	–	–	0.01%	80
2024 Q1	$27.1K	Sell	200 -89	-31%	-$11.8K	0.01%	96
2023 Q4	$38.9K	Buy	289 +89	+45%	+$11.6K	0.01%	75
2023 Q3	$27.1K	Hold	200	–	–	0.01%	75
2023 Q2	$28.6K	Hold	200	–	–	﹤0.01%	73
2023 Q1	$27.8K	Sell	200 -10,043	-98%	-$1.35M	﹤0.01%	78
2022 Q4	$1.39M	Buy	+10,243	New	+$1.28M	0.17%	33

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return